Pubblicazioni

Low density lipoprotein (LDL) cholesterol as a causal role for atherosclerotic disease. potential role of PCSK9 inhibitors

2019 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Del Pinto, R.; Grassi, D.; Properzi, G.; Desideri, G.; Ferri, C.

Usefulness of nutraceuticals (armolipid plus) versus ezetimibe and combination in statin-intolerant patients with dyslipidemia with coronary heart disease

2015 - THE AMERICAN JOURNAL OF CARDIOLOGY

Marazzi, Giuseppe; Pelliccia, Francesco; Campolongo, Giuseppe; Quattrino, Silvia; Cacciotti, Luca; Volterrani, Maurizio; Gaudio, Carlo; Rosano, Giuseppe